Skip to main content
OpenTrials
Completed

NCT Number: NCT02656641

Using the PHQ-9 and GAD-7 as Feedback Instruments in Brief Psychotherapy

This study will assess the effects of client feedback, using the Patient Health Questionnaire - 9 and Generalized Anxiety Disorder 7-Item Scale, on depression and anxiety in individuals undergoing brief psychotherapy. Client feedback allows therapists to monitor treatment progress in real time. Identifying an easily accessible treatment intervention, which utilizes commonly used scales, that potentially enhances the effect of brief psychotherapy and improves treatment outcomes is a valuable endeavor with clear implications for therapy practices. It is hypothesized that clients who complete these scales each session will show greater symptom improvement than clients who do not complete the scales.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depressive Symptoms Anxiety Disorders Anxiety States, Neurotic Behavior Behavioral Symptoms Depression Mental Disorders

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Christiana Care Health System - Adult Bridge Program

Wilmington, Delaware, 19801, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of Major Depressive Disorder, Generalized Anxiety Disorder, or Adjustment Disorder

Exclusion criteria

  • Require a higher level of care than brief psychotherapy, or have been diagnosed with an intellectual disability, personality disorder, substance use disorder, or major medical illness

Treatment and study plan

Continuous Client Feedback

Behavioral

Clients complete rating scales before each therapy session. The therapist then views these results and discusses treatment progress with the client during the session.

Continuous Self Feedback

Behavioral

Clients complete rating scales before each therapy session. Progress is not reviewed with the therapist.

Primary outcomes

  1. Change in depressive symptoms as assessed by Patient Health Questionnaire-9

    Time frame: Baseline and end of treatment up to 10 weeks

    Assesses depressive symptoms

  2. Change in anxiety symptoms as assessed by Generalized Anxiety Disorder 7-Item Scale

    Time frame: Baseline and end of treatment up to 10 weeks

    Assesses anxiety symptoms

Secondary outcomes

  1. World Health Organization - Quality of Life BREF Scale

    Time frame: Baseline and end of treatment up to 10 weeks

    Assesses domains of physical health, psychological health, social relationships, and environment

  2. Schwartz Outcome Scale

    Time frame: Baseline and end of treatment up to 10 weeks

    Monitors treatment outcomes

Sponsors and collaborators

Lead sponsor

Christiana Care Health Services

Other

Collaborators

  • Immaculata University

Registry information

Official study title

Using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder 7-Item Scale (GAD-7) as Feedback Instruments in Brief Psychotherapy

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jan 15, 2016
Registry last updated
Jul 19, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.